Sign in

The Travelers Companies, Inc. TRV

Price 374.3 USD
as of 2026-09-05
68/100
Constructive
Quality66
Growth67
Balance-sheet strength60
Valuation79
Momentum78
Income51

Composite 68/100; the shares have moved about 24% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Its least supportive area is Income at 51 — still above average.

Case for

Valuation ranks 79/100 — a strong point in its favour. Momentum ranks 78/100 — a strong point in its favour. Growth ranks 67/100 — a moderate point in its favour.

Case against

Its least supportive area is Income at 51 — still above average.

What the company does The Travelers Companies (TRV) underwrites commercial and personal property and casualty insurance across the U.S., Canada, and internationally through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance.

Key financials TRV posts a 26.5% ROE, 4.8% ROA, and 17.0% net margin. Revenue growth is 0.3% while EPS grew 57.1%. Gross, operating, and net margins are 34.7%, 23.7%, and 17.0%, respectively.

Stock health Momentum is strong: 3m 25.60%, 6m 33.08%, 12m 48.32%. RSI(14) is 63.40, and TRV is -5.41% below its 52-week high. Sideravia scores Valuation 83.0 and Momentum 75.5.

Price vs fair value TRV trades at a PREMIUM of 4.50% versus the analyst mean target of 360.33. - Recent synergy rollout in life sciences liability coverage (Simply Wall St.) - Zacks highlights TRV among top momentum picks (Zacks) - Featured in non-tech momentum list amid Dow rally (Zacks)

Looking forward Forward P/E is 13.26 vs trailing 10.45, suggesting valuation expansion is already reflected. Debt/Equity is 0.27 and net debt/EBITDA is 0.35, indicating moderate leverage.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.